The stock has been a handful of traders trying to work the price down for a few weeks. Watch BMAK on the ask constantly trying to move it down. Trying to get someone to put in an ask ahead of him. And then he will bid sit and work it down.
They are going to run this one hard again. With a cap sitting around $110m and positive clinical trials and more expected plus NDA filing (probably several once they know what the FDA is fully expecting-officially since they probably already know through Camargo)
You are looking at 4-6x gains maybe more.
Also expect a marketing and sales deal here too since they are doing that DD now.
This is about as great a risk/reward as you will find right now. Little risk and very high reward.
News 
Market Data 
Discover 
